ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening Program

Clinical trial NCT05368038 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT05368038
Sponsor: Albert Einstein College of Medicine
Status: ENROLLING_BY_INVITATION
Study type: OBSERVATIONAL

Acid Sphingomyelinase Deficiency Ceroid Lipofuscinosis, Neuronal, 2 Cerebrotendinous Xanthomatosis Fabry Disease GM1 Gangliosidosis Gaucher Disease Lysosomal Acid Lipase Deficiency Metachromatic Leukodystrophy Mucopolysaccharidosis II Mucopolysaccharidosis III-B Mucopolysaccharidosis IV A Mucopolysaccharidosis VI

Start date: 2021-05-10
Primary completion: 2029-08-31
Enrollment: 100000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.